Stress, ageing, cancer. There are still no magic solutions but one factor linking all three holds out hope. And that, says Nobel Laureate Jack Szostak, is the telomere, which lies at the end of ...
The first leukaemia patient to receive a breakthrough treatment since it was made available on the NHS has said it was ...
Weizmann Institute researchers say that progesterone and the stress hormone cortisol drive circadian rhythms; when out of ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
The result is a record 18 million cancer survivors in the US right now, a number expected to grow between 300,000 and 500,000 ...
The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.
Zacks Small Cap Research on MSN

YDES is a biotechnology company on the move

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...
Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...
Probiotics are microbes that pacify your immune system and prevent the collateral damage from an overactive inflammatory response. Here’s how to put them to work.
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...